scholarly journals Predictive Value of Nuclear Factor κB Activity and Plasma Cytokine Levels in Patients with Sepsis

2000 ◽  
Vol 68 (4) ◽  
pp. 1942-1945 ◽  
Author(s):  
Francisco Arnalich ◽  
Esther Garcia-Palomero ◽  
Julia López ◽  
Manuel Jiménez ◽  
Rosario Madero ◽  
...  

ABSTRACT The relationship between fluctuating cytokine concentrations in plasma and the outcome of sepsis is complex. We postulated that early measurement of the activation of nuclear factor κB (NF-κB), a transcriptional regulatory protein involved in proinflammatory cytokine expression, may help to predict the outcome of sepsis. We determined NF-κB activation in peripheral blood mononuclear cells of 34 patients with severe sepsis (23 survivors and 11 nonsurvivors) and serial concentrations of inflammatory cytokines (interleukin-6, interleukin-1, and tumor necrosis factor) and various endogenous antagonists in plasma. NF-κB activity was significantly higher in nonsurvivors and correlated strongly with the severity of illness (APACHE II score), although neither was related to the cytokine levels. Apart from NF-κB activity, the interleukin-1 receptor antagonist was the only cytokine tested whose level in plasma was of value in predicting mortality by logistic regression analysis. These results underscore the prognostic value of early measurement of NF-κB activity in patients with severe sepsis.

Circulation ◽  
2000 ◽  
Vol 102 (9) ◽  
pp. 1020-1026 ◽  
Author(s):  
Luis Miguel Blanco-Colio ◽  
Mónica Valderrama ◽  
Luis Antonio Alvarez-Sala ◽  
Carmen Bustos ◽  
Mónica Ortego ◽  
...  

2007 ◽  
Vol 35 (10) ◽  
pp. 2395-2401 ◽  
Author(s):  
Noriko Hotta ◽  
Takashi Ichiyama ◽  
Masahiro Shiraishi ◽  
Tsuyoshi Takekawa ◽  
Tomoyo Matsubara ◽  
...  

2015 ◽  
Vol 11 (2) ◽  
pp. 115 ◽  
Author(s):  
Peggy Compton, RN, PhD ◽  
Charles Griffis, CRNA, PhD ◽  
Elizabeth Crabb Breen, PhD ◽  
Matthew Torrington, MD ◽  
Ryan Sadakane, BS ◽  
...  

Objective: To determine the independent and combined effects of pain and opioids on the activation of an early marker of inflammation, nuclear factor-κB (NF-κB).Design: NF-κB activation was compared within-subjects following four randomly ordered experimental sessions of opioid-only (intravenous fentanyl 1 μg/kg), pain-only (cold-pressor), opioid + pain, and a resting condition.Setting: University General Clinical Research Center.Participants: Twenty-one (11 female) healthy controls.Interventions: Following exposure to treatment (fentanyl administration and/or cold-pressor pain), blood samples for NF-kB analysis were obtained.Main outcome measures: Intracellular levels of activated NF-κB, in unstimulated and stimulated peripheral blood mononuclear cells at 15 and 30 minutes.Results: Neither pain nor opioid administration alone effected NF-κB levels in cell populations; however, the combination of treatments induced significant increases of NF-κB in stimulated peripheral blood mononuclear cell, lymphocytes, and monocytes.Conclusions: The combination of acute pain with opioids, as occurs in clinical situations, activates a key transcription factor involved in proinflammatory responses.


Sign in / Sign up

Export Citation Format

Share Document